Abstract
A library of pyrazolinyltriazole hybrids (3a–l, 4a–l) was synthesized via azide–alkyne dipolar (Huisgen) cycloaddition of azidoacetyl pyrazoline and acetylenedicarboxylic esters under solvent-free condition. The in vitro antibacterial activity of the hybrids was studied against four human pathogens, viz. Escherichia coli (ATCC 25922), Klebsiella pneumonia (ATCC 13883), Proteus mirabilis (ATCC 12453), and Staphylococcus aureus (ATCC 29213), compared with that of ciprofloxacin as standard drug. Six of the 24 compounds synthesised [3d, k, l and 4d, k, l with minimum inhibitory concentration (MIC) of 3.9 µg/mL] were found to be more potent than ciprofloxacin. In fact, the high antibacterial activity of all 24 new compounds against S. aureus reveals that such compounds with this pyrazolinyltriazole skeleton may emerge as a new class of potential antibacterial agents. Furthermore, the other three pathogens were also effectively inhibited by most of the synthesized compounds (3a, c, d, g, k, l, 4a–e, h–l). Synthesis of the heterocyclic hybrids 3, 4, identification of their core skeleton, and their structure–activity relationship are reported herein.
Graphical Abstract
Similar content being viewed by others
Notes
WHO report, March 2012, 10 facts on antimicrobial resistance.
Commercially available with CAS no. 438228-92-3 and 438231-42-6, respectively.
References
L.K. Siu, K.-M. Yeh, J.-C. Lin, C.-P. Fung, F.-Y. Chang, Lancet Infect. Dis. 12, 881 (2012)
R.A. Polin, L. Saiman, Neo Rev. 4, 81 (2003)
A.R. Marra, S.B. Wey, A. Castelo, A.C. Gales, R.G. Cal, J.R. Filho, M.B. Edmond, C.A.P. Pereira, BMC Infect. Dis. 6, 24 (2006)
H. Harikrishnan, A. Naif Abdullah, K. Ponmurugan, R. Shyam Kumar, Chalcogenide Lett. 9, 509 (2012)
L. Balducci, J.C. Halbrook, S.W. Chapman, R.B. Vance, J.T. Thigpen, F.S. Morrison, Am. J. Hematol. 15, 57 (1983)
V.D. Joshi, M.D. Kshirsagar, S. Singhal, Int. J. ChemTech Res. 4, 971 (2012)
M. Amir, H. Kumar, S.A. Khan, Bioorg. Med. Chem. Lett. 18, 918 (2008)
T. Taj, R.R. Kamble, T.M. Gireesh, R.K. Hunnur, S.B. Margankop, Eur. J. Med. Chem. 46, 4366 (2011)
N. Beyhan, B. K. Kaymakcioglu, S. Gumru, F. Aricioglu, Arab. J. Chem. (2013). Doi:10.1016/j.arabjc.2013.07.037. (in press)
M. Himaja, D. Munirajasekhar, A. Karigar, M.V. Ramana, M. Sikarwar, Asian J. Chem. 24, 2789 (2012)
V.H.S. Jois, B. Kalluraya, K.S. Girisha, J. Serb. Chem. Soc. 79, 1469 (2014)
S. Shafi, M.M. Alam, N. Mulakayala, C. Mulakayala, G. Vanaja, A.M. Kalle, R. Pallu, M.S. Alam, Eur. J. Med. Chem. 49, 324 (2012)
P. Shanmugavelan, S. Nagarajan, M. Sathishkumar, A. Ponnuswamy, P. Yogeeswari, D. Sriram, Bioorg. Med. Chem. Lett. 21, 7273 (2011)
A. Kamal, N. Shankaraiah, V. Devaiah, K.L. Reddy, J. Aarti, S. Subrata, K. Nisha, S. Zingde, Bioorg. Med. Chem. Lett. 18, 1468 (2008)
R.C.N.R. Corrales, B.D.S. Nicolli, L.S. Pinheiro, C. Abramo, E.S. Coimbra, A.D.D. Silva, Biomed. Pharmacother. (2010). Doi:10.1016/j.biopha.2010.10.013
A.K. Jordao, P.P. Afonso, V.F. Ferreira, M.C.B.V. de Souza, M.C.B. Almeidaa, C.O. Beltrame, D.P. Paiva, S.M.S.V. Wardell, J.L. Wardell, E.R.T. Tiekink, C.R. Damaso, A.C. Cunha, Eur. J. Med. Chem. 44, 3777 (2009)
B.S. Holla, M. Mahalinga, M.S. Karthikeyan, B. Poojary, P. M. Akberali, N. S. Kumari. Eur. J. Med. Chem. 40, 1173 (2005)
X.-L. Wang, K. Wan, C.-H. Zhou, Eur. J. Med. Chem. 45, 4631 (2010)
S. Nagarajan, P. Shanmugavelan, M. Sathishkumar, R. Selvi, A. Ponnuswamy, H. Hariharan, V. Shanmugaiah, Chin. Chem. Lett. 25, 419 (2014)
S. Nagarajan, M. Sathishkumar, P. Shanmugavelan, R. Ranganathan, A. Ponnuswamy, R. Venkatesan, V. Shanmugaiah, Eur. J. Med. Chem. 58, 464 (2012)
S. Archana, M. Dinesh, R. Ranganathan, M. Sathishkumar, P. Shanmugavelan, A. Ponnuswamy, Synth. Commun. 45, 2748 (2015)
J.G. Colle, R.S. Miles, B. Watt, Tests for the identification of bacteria, in Mackie and Mc Cartney Practical Medical Microbiology, 14th edn., ed. by J.G. Collee, A.G. Fraser, B.P. Marmion, A. Simmons (Churchill Livingstone, Edinburgh, 1996)
L. Essers, K. Radebold, Clin. J. Microbiol. 12, 641 (1980)
National Committee for Clinical Laboratory Standards (NCCLS), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved standard NCCLS publication M7-A3, NCCLS, Villanova, PA, USA, 3rd edition (1993)
Acknowledgments
The authors thank IRHPA, DST for providing 300 MHz NMR instrument for recording NMR spectra for the synthesized compounds, and UGC-BSR for giving financial support.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Archana, S., Ranganathan, R., Dinesh, M. et al. Design, synthesis, and antibacterial studies of potent pyrazolinyltriazoles. Res Chem Intermed 43, 2471–2490 (2017). https://doi.org/10.1007/s11164-016-2774-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-016-2774-6